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Abstract
This study examines whether subretinal transplantation of a human retinal pigment epithelial cell line (ARPE19) or human
Schwann cells early in the course of degeneration can limit the loss of visual acuity that normally occurs in dystrophic Royal College
of Surgeons (RCS) rats as they age. The acuity of both transplanted groups was signiﬁcantly better than controls at all ages tested,
though the rescue proﬁle of each cell type was unique. These data indicate that the transplantation of cells with very diﬀerent phe-
notypes can be used to limit the deterioration of spatial vision in an animal model of retinal degenerative disease.
 2004 Elsevier Ltd. All rights reserved.
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Photoreceptor degeneration due to defects of either
the photoreceptors themselves or of the adjacent retinal
pigment epithelial (RPE) cell layer constitutes a major
cause of blindness worldwide (Berson, Dunn, & Takao,
2002; Fine, Berger, Maguire, & Ho, 2000; Phelan &
Bok, 2000). Studying the causes, consequences and
potential treatments for these conditions is aided by
the availability of animal models with natural mutations
providing phenotypes that are homologous or analo-
gous to those seen in patients (Acland et al., 2001; Al-
eman et al., 2001; Cao, Li, Steinberg, & Lavail, 2001;
DCruz et al., 2000; Farber, 1995; LaVail, 1981, 2001;
Machida et al., 2000; Ohara, Tauscher, & LaVail,
2001; Olsson et al., 1992; Ren et al., 2001; Rohrer, La-
Vail, Jones, & Reichardt, 2001; Vollrath et al., 2001).0042-6989/$ - see front matter  2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2004.05.025
* Corresponding author. Tel.: +1-4033943937.
E-mail address: mcgitj@uleth.ca (T.J. McGill).Although numerous studies have slowed the progress
of photoreceptor degeneration in animal models of reti-
nal degenerative diseases (e.g. Acland et al., 2001; Ali et
al., 2000; Li et al., 1998), very little attention has been
paid to how photoreceptor rescue translates into rescue
of centrally-mediated visual functions, in particular spa-
tial vision. This is surprising given that progressive loss
of vision is the most insidious and debilitating conse-
quence of retinal degeneration, and preventing its de-
cline would be the ultimate measure of a successful
treatment.
Recently, we examined how visual acuity deteriorates
during the course of retinal degeneration in the RCS rat
(McGill, Douglas, Lund, & Prusky, 2004), an animal in
which photoreceptors degenerate as the result of a
Mertkmutation (DCruz et al., 2000). The mutation ren-
ders RPE cells unable to perform their normal support-
ive role to the photoreceptors (Chaitin & Hall, 1983;
Dowling & Sidman, 1962) resulting in progressive pho-
toreceptor death. We found in these animals that acuity
was near normal at one month of age, but that vision
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was reached by 11 months.
Among the potential treatments for retinal degenera-
tive disease is the subretinal transplantation of cells. One
approach has been to provide an alternative RPE cell
type to replace the physiological function of defective
cells (Lund et al., 2001). The human-derived RPE cell
line, ARPE19, exempliﬁes many features typical of
RPE cells (Kanuga et al., 2002), and when transplanted
into the retina of young RCS rats, slows the progress of
photoreceptor loss (Coﬀey et al., 2002), the deterioration
of retinal sensitivity (Sauve, Girman, Wang, Keegan, &
Lund, 2002; Yamamoto, Du, Gouras, & Kjeldbye,
1993), and the physiological response speciﬁcity of single
units in the primary visual cortex (Girman, Wang, &
Lund, 2003). Another approach has been to transplant
primary cultures of Schwann cells: these have been
shown to rescue photoreceptors from degeneration in
both RCS rats and rhodopsin knockout mice (Keegan
et al., 2003; Lawrence et al., 2000, 2004) and to slow
the decline in visual responsiveness (measuring physio-
logical properties in the superior colliculus) and a be-
havioral parameter (measuring head tracking responses
to a rotating drum) in RCS rats (Lawrence et al.,
2000). The rationale of the Schwann cell eﬀect is pre-
sumed to lie in the fact that they are known to produce
a range of growth factors (Hammarberg et al., 1996; Ne-
uberger & De Vries, 1993), which have been shown,
when introduced into the eye, to protect photoreceptors
from degeneration (Carwile, Culbert, Sturdivant, &
Kraft, 1998; Faktorovich, Steinberg, Yasumura, Mat-
thes, & LaVail, 1992; Perry, Du, Kjeldbye, & Gouras,
1995). Until now, there has been no systematic quantita-
tive study, examining spatial vision thresholds in ani-
mals with subretinal cell transplants. The object of the
present study is to evaluate whether the subretinal trans-
plantation of ARPE19 or human Schwann cells can
slow the progressive loss of visual acuity in the RCS
rat. If either treatment were successful, it would provide
essential validation for using cell-based therapies to treat
retinal degenerative disease.2. Materials and methods
2.1. Animals
Forty-ﬁve pigmented dystrophic RCS rats were used
in this study. Data from a previous study (McGill et al.,
2004) examining acuity using identical testing conditions
in non-dystrophic and unoperated dystrophic rats pro-
vided background reference material. The animals were
housed and handled with the authorization and super-
vision of the Institutional Animal Care and Use Com-
mittee (IACUC) at the University of Utah, and the
University of Lethbridge animal care committee. Ani-mals were cared for in accordance with National Insti-
tute of Health (NIH) and Canadian Council on
Animal Care (CCAC) guidelines.
Animals were housed in isolated rooms with a 12 h
dark/light cycle, a constant temperature of 22 C, and
where food and water were available ad libitum. All ani-
mals were maintained on cyclosporin A, administered in
the drinking water (210 mg/l) resulting blood concentra-
tion of around 300 lg/l (Coﬀey et al., 2002) from one
day prior to transplantation until they were sacriﬁced
after all behavioral testing was completed.
2.2. Transplantation
Two donor cell types were used for transplantation.
The ﬁrst was the extended life human ARPE19 cell line
(ATCC; Dunn, Aotaki-Keen, Putkey, & Hjelmeland,
1996) (which was stored in liquid nitrogen prior to
removing, culturing and preparing for transplantation
as described elsewhere, Lund et al., 2001). The second
was a human Schwann cell culture isolated from organ
donors using a methodology described elsewhere
(Casella, Bunge, & Wood, 1996). Two control groups
were also used. The ﬁrst group was a sham operated
control in which only vehicle was injected. The second
utilized ﬁbroblasts as a control cell type for Schwann cell
transplantation, because it is likely that the Schwann cell
cultures were contaminated with a small number of ﬁ-
broblasts. In addition, unoperated non-dystrophic and
dystrophic rats used in a previous study (McGill et al.,
2004) provided reference material.
The transplantation procedure that was used has
been detailed elsewhere (Lawrence et al., 2000; Lund
et al., 2001). Brieﬂy, rats were anesthetized with 2,2,2 tri-
bromoethanol (230 mg/kg) and topical Ophthaine was
placed on the eye prior to surgery. The pupil was dilated
with tropicamide and the eye was proptosed slightly
using a thread. Donor cells were plated in a poly-L-ly-
sine-coated ﬂask in a medium including DMEM con-
taining 10% fetal bovine serum, heregulin peptide,
forskolin, pituitary extract, penicillin/streptomycin and
gentamycin (Schwann cells) or DMEM/F12 containing
10% fetal bovine serum (ARPE19 cells). Cultures were
trypsinized, washed and delivered into the subretinal
space through a small scleral incision as a suspension
in 2 ll of DMEM alone (Schwann cells) or DMEM/
F12 (ARPE19 cells) using a ﬁne glass pipette (internal
diameter 75–150 lm) attached by tubing to a 10 ll Ham-
ilton syringe. The cell suspensions contained about
2·105 ARPE19 cells, 2·104 Schwann cells and 2·104
ﬁbroblasts, respectively. The cornea of the recipient
eye was punctured to reduce intraocular pressure and
to limit the eﬄux of cells. Immediately after injection,
the fundus was examined to check for retinal damage
or signs of vascular distress, and any animals showing
such problems were removed from the study. Samples
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and end of a transplantation session using Trypan blue
staining. A typical ﬁgure of greater than 95% intact cells
was obtained at both time points. Sham animals re-
ceived injection of carrier medium and were otherwise
treated identically to the cell transplant groups.
2.3. Visual Water Task
The grating acuity of all animals was assessed using
the Visual Water Task, which is a visual perception task
that has been described in detail previously (McGill
et al., 2004; Prusky, Lu, Douglas, & Lund, 2002; Prusky,
West, & Douglas, 2000). Brieﬂy, the apparatus consisted
of a trapezoidal-shaped pool with two computer moni-
tors facing through a clear glass wall into the wide end
of the pool and a midline divider extending into the pool
from between the monitors, creating a Y-maze with a
stem and two arms. Animals are trained to discriminate
between diﬀerent visual stimuli generated and projected
on the screens using a computer program (Vista;
CerebralMechanics).
Training and testing followed the same procedure as
described elsewhere (McGill et al., 2004) except that ani-
mals in this study were tested once per month commenc-
ing at four months of age. ARPE19 transplanted and
sham animals were tested up to seven months of age
at the University of Lethbridge, at which point they
were transported to the University of Utah for physio-
logical and anatomical analyses (Sauve´, Lu, & Lund,
2003). The Schwann cell and ﬁbroblast transplanted ani-
mals were tested up to ﬁve months of age and then
shipped to the University of Utah for further study
(Wang, Lu, Wood, Lawrence, & Lund, 2003). In order
to collect correlative data at a stage when performance
was optimal, post-surgical testing of the Schwann cell
group was not extended to seven months of age.Fig. 1. Frequency of seeing curves used to calculate the acuity of an
animal from each treatment group (ARPE19, vehicle, Schwann cells,
and ﬁbroblasts) on task performance at four months of age. Non-
dystrophic animals were tested at six months of age (McGill et al.,
2004). Arrows point to the thresholds calculated from each curve. A
high level of performance was displayed at spatial frequencies below
threshold for all animals.3. Results
This study is built on the base of a previous study
conducted under identical conditions on unoperated
non-dystrophic and dystrophic RCS rats. In that study,
Long–Evans rats were also examined to see whether
non-dystrophic rats behaved similarly. The results
showed that non-dystrophic RCS rats and Long–Evans
rats performed identically with an average grating acuity
slightly higher than 1.0 c/deg. By contrast, dystrophic
rats at one month of age had an acuity of 0.82 c/deg
and this fell to 0.32 c/deg by four months and showed
a slower decline thereafter. A signiﬁcant diﬀerence be-
tween that and the present work was that the animals
were not maintained on cyclosporine. Comparison be-
tween the medium alone shams in the present experi-
ment and the unoperated dystrophics of the previousstudy conﬁrmed that this was not a signiﬁcant factor
(see Section 3.3).
3.1. Training
All rats readily learned to associate swimming to the
platform with escape from the water. On average, about
150 trials (i.e. four–ﬁve days of testing) were required for
animals to reach 90% accuracy over 40 trials and there
were no obvious group diﬀerences in this ability.
3.2. Testing
During testing, all animals maintained a high level of
performance at spatial frequencies below threshold and
made very few, if any, errors. As the spatial frequencies
neared threshold values, the animals made an increasing
number of errors until performance dropped below 70%.
Although the grating thresholds generally decreased
with age, there was no evidence of any accompanying
cognitive deﬁcits, motor deﬁcits, or lack of general abil-
ity to perform the task. All standard error values were
less than 0.05. Fig. 1 displays frequency-of-seeing curves
for a representative animal from each group at four
Fig. 2. Eﬀect of subretinal ARPE19 transplantation on the grating
acuity of dystrophic RCS rats compared with sham surgery (vehicle
injections); measured in the Visual Water Task. The ARPE19 group
performed signiﬁcantly better than the sham group at all time points
(F(3,78)=7.147, P=0.000). Standard errors were calculated but proved
to be smaller than the data point symbols. The star and dotted line
indicates the visual acuity of non-dystrophic RCS rats at six months of
age: data from McGill et al. (2004).
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between animals, the shapes of the functions are
remarkably similar, indicating that an animals perform-
ance in the task is not dependant upon acuity thresh-
olds.
3.3. Sham controls
Eighteen animals were used as sham operated con-
trols. These animals were tested from four to seven
months of age, over which time the groups average acu-
ity dropped from 0.445 to 0.265 c/deg. An analysis of
variance conﬁrmed that the visual acuity of the sham ani-
mals decreased signiﬁcantly with age (F(3,45)=33.935,
P=0.000). The acuities of the sham animals followed
the same degenerative proﬁle over time as that of unop-
erated dystrophic animals (McGill et al., 2004), and there
was no signiﬁcant diﬀerence (F(3,60)=2.337, P=0.083)
between sham and unoperated animals from four to
seven months of age. In comparison with non-dystrophic
animals that sustained a visual acuity of around 1.0 c/
deg, the sham operated animals acuity was approxi-
mately half at four month and one quarter at seven
months of age.
3.4. Fibroblast controls
Six animals were used as ﬁbroblast controls. They
were tested at four and ﬁve months of age. The average
acuity of 0.46 c/deg at four months fell to 0.36 c/deg by
ﬁve months of age. However, this change was not signif-
icant (F(1,11)=3.968, P=0.140) and the mean acuity of
the ﬁbroblast controls was indistinguishable from that
of sham animals at four–ﬁve months.
3.5. ARPE19
The grating acuity of the 12 dystrophic RCS rats with
ARPE19 cell transplants was tested from four to seven
months of age. Transplanted animals exhibited an aver-
age visual acuity of 0.69 c/deg at four months, which fell
to 0.38 c/deg by seven months. The best animals per-
formed at 0.72 c/deg at four months and at ﬁve months
gave a ﬁgure of 0.55 c/deg which is also the group mean.
An analysis of variance was used to compare ARPE19
and sham operated control groups. There was a signiﬁ-
cant eﬀect of age on ARPE19 transplantation
(F(3,33)=78.652, P=0.000) and a signiﬁcant age· treat-
ment interaction (F(3,78)=7.147, P=0.000). Posthoc
comparisons showed that ARPE19 transplanted animals
had a higher acuity than sham controls at all ages. Fig. 2
shows the average grating acuity of the ARPE19 trans-
planted group compared with the sham transplanted
animals at each age tested (four–seven months).
The mean acuity of the ARPE19 cell transplanted
animals at four months of age was approximately 70%of non-dystrophic animals. This fell to about 40% of
normal by seven months of age, with best performing
animals showing ﬁgures of 0.82 and 0.46 c/deg at four
and seven months respectively. However, the mean acu-
ity of the transplant group was still approximately twice
that of shams or unoperated controls (McGill et al.,
2004). In addition, the acuity of the best performing ani-
mals with ARPE19 cell transplants at four months of
age was the same as unoperated dystrophic animals at
one month of age.
3.6. Schwann cells
The grating acuities of the nine dystrophic RCS rats
with Schwann cell transplants were tested at four and
ﬁve months of age. The mean acuity of the group was
0.57 c/deg at four months of age, and this remained vir-
tually unchanged at ﬁve months of age (0.55 c/deg; no
signiﬁcant eﬀect of age F(1,8)=1.561, P=0.247). The
two best performers gave ﬁgures of 0.72 c/deg and
showed no signiﬁcant deterioration between the two
time points. An analysis of variance was used to com-
pare Schwann cell transplant group with sham operated
and ﬁbroblast controls. There was no signiﬁcant diﬀer-
ence between the ﬁbroblast group and the sham group
(F(1,18)=0.017, P=0.898). There was a signiﬁcant group
eﬀect of Schwann cells when compared with sham ani-
mals (F(1,23)=10.738, P=0.003) and with ﬁbroblasts
(F(1,11)=6.017, P=0.029), as well as a signiﬁcant
age· treatment interaction (F(1,11)=5.153, P=0.035).
This indicated that the acuity of the Schwann cell group
was signiﬁcantly better than both control groups, even
Fig. 3. The visual acuity of each treatment group at four and ﬁve
months of age. Both ARPE19 and Schwann cell transplantation
resulted in a signiﬁcant beneﬁt to vision, although the pattern of the
rescue diﬀered. Standard error bars are included in the graph; however,
they are smaller than the data point symbols. The star and dotted line
indicates visual acuity of non-dystrophic RCS rats at six months of age
which is data from McGill et al. (2004). See text for details.
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cantly with age.
The mean acuity of the Schwann cell transplanted
animals at both ages tested was approximately half that
of normal non-dystrophic animals with the best animals
performing better than 70% of non-dystrophics and 87%
of one month old dystrophics (Fig. 3).
3.7. Cell type comparison
Although the Schwann cell transplanted animals as a
group had a mean acuity that was signiﬁcantly better
than both control groups (medium alone and ﬁbro-
blasts), it was not as high as the ARPE19 transplants
at four months of age. However, the best Schwann cell
transplanted animals performed better than 0.70 c/deg
and were able to sustain this level over the course of
the next month; whereas the best ARPE19 animals also
performed above 0.70 c/deg at four months but fell to
0.55 c/deg by ﬁve months of age. An analysis of variance
was used to compare the ARPE19 and Schwann cell
groups. The acuity of ARPE19 transplanted animals sig-
niﬁcantly decreased from four to ﬁve months of age
(F(1,11)=27.547, P<0.000), whereas the Schwann cell
group did not (F(1,8)=1.561, P=0.247). There was no
signiﬁcant group diﬀerence between Schwann cells and
ARPE19 cells (F(1,19)=1.875, P=0.187) (Fig. 3).4. Discussion
The results of this study show that the Visual Water
Task can be used in RCS rats to quantify the eﬀects ofcell transplantation on visual acuity over time. In addi-
tion, they show that the two cell types transplanted here,
which had been shown previously to rescue photorecep-
tors, can also preserve spatial vision, in best cases to bet-
ter than 70% of normal at four months of age. At all
ages tested, ARPE19 and Schwann cell transplanted ani-
mals signiﬁcantly outperformed controls. All animals,
both transplanted and sham operated performed compe-
tently in the task even as their vision deteriorated, indi-
cating that only threshold values, and not general
behavioral proﬁciency, changed over time. Similarly,
the treatment condition did not appear to aﬀect the abil-
ity of animals to distinguish salient visual stimuli, signi-
fying that the eﬀects of cell transplantation can be
directly evaluated.
It is clear that ARPE19 transplantation provided a
signiﬁcant beneﬁt to vision. This builds on previous
work showing that diﬀerent RPE cells, either freshly
harvested or using immortalized cell lines as used here,
not only preserve photoreceptors but also visual respon-
siveness (Coﬀey et al., 2002; Lund et al., 2001). A range
of visual behaviors have been shown to be preserved by
this treatment including parameters of the ERG re-
sponse (Sauve´ et al., 2003) and pupillary light reﬂex
(Whiteley, Litchﬁeld, Coﬀey, & Lund, 1996) as well as
relative retinal sensitivity in the area of graft preserva-
tion (Sauve et al., 2002) single unit physiological re-
sponses in the visual cortex (Girman, Wang, et al.,
2003) and head tracking to a rotating drum (Coﬀey et
al., 2002). No studies, however, have systematically
measured visual perception. Some measures of visual
function, such as ERG and head tracking, are not gen-
erally sustained for long periods, even though other
methods such as cortical physiology show continued
functional rescue. Previous ARPE19 transplant studies
used a terrestrial two-choice test to measure visual func-
tion (Coﬀey et al., 2002), which was only able to record
visual thresholds up to 0.35 c/deg, which is a far lower
threshold than can be measured in rats in a range of
tests including the Visual Water Task. Although the ter-
restrial task was able to discriminate performance in
grafted vs unoperated dystrophics, it failed to discrimi-
nate between grafted and non-dystrophic animals (Cof-
fey, Whiteley, & Lund, 2000). In that study, tested
animals were selected on superior performance in an ini-
tial screening; furthermore performance was not tested
over an extended period against performance in con-
trols. Here we tested all animals in the group, bearing
in mind that some may have had inadequate transplants.
The Visual Water Task, used here is a higher resolution
test and has made it possible to identify small variances
in performance among animals and groups: its ease of
performance makes it preferable to other methods used
for testing rat vision. This study adds further support to
the possibility that ARPE19 transplantation may be a
viable treatment for retinal degenerative disease,
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ical and basic functional measures of the visual system,
but it preserves acuity in best cases at a level close to that
recorded in non-dystrophic pigmented rats.
Previous work on Schwann cell transplantation in
RCS rats (Lawrence et al., 2000, 2004) showed that the
cells survived in the subretinal space, rescued photore-
ceptors, sustained visual threshold responses recorded
from the superior colliculus, slowed the deterioration
of head tracking and preserved the receptive ﬁeld proper-
ties of cortical neurons (Girman, Wang, et al., 2003). We
now show here that visual acuity, measured in a visual
perception task, is also improved over unoperated rats.
This beneﬁt is most likely related to the ability of
Schwann cells to produce a range of neurotrophic fac-
tors, including CNTF, GDNF and BDNF, which are
known to preserve photoreceptors when introduced into
the eye (Neuberger & De Vries, 1993; Sendtner, Stockli,
& Thoenen, 1992), and as such serves as a cell-based
growth factor delivery approach. Because there is always
the possibility of some contamination with ﬁbroblasts in
the isolation procedure, a ﬁbroblast control was an
important step to rule out the possibility that these cells
might responsible for at least some of the rescue.
Previous work using the Visual Water Task (McGill
et al., 2004) has shown that adult non-dystrophic RCS
rats have acuity thresholds around 1.0 c/deg, which is
normal for standard pigmented laboratory rats (Prusky
et al., 2002). Other more cumbersome methods have
found similar grating thresholds (Dean & Pope, 1981)
but these methods are less suitable to the serial testing
from an early age that is a central feature of our study.
The acuity of unoperated dystrophic RCS rats, however,
is not normal: at one month it is around 0.8 c/deg, and it
deteriorates to 0.32 c/deg by four months. In the present
study, it is remarkable that at four months the animals
with the highest acuity in both the ARPE19 and
Schwann cell transplanted groups was better than 0.7
c/deg. This is well above the average acuity of sham
operated and ﬁbroblast control animals, which degener-
ated over time with a pattern similar to that observed in
unoperated dystrophic RCS rats (McGill et al., 2004). It
should be noted that animals were not prescreened prior
to functional testing, and based on previous experience,
may have included some in which the transplantation
was unsuccessful. The delay between cessation of be-
havioral testing and anatomical evaluation made it diﬃ-
cult to deﬁne whether poor anatomical rescue was the
result of deterioration with time or an inadequate trans-
plant at the outset. With this uncertainty, detailed com-
parison between the two sorts of transplant is not
justiﬁed. However, it can be presumed that the best ani-
mals represent the optimal circumstances and since both
gave similar results for the best performers, this indi-
cates that both cell types might give comparable results
under optimal conditions.The Visual Water Task employs a two-choice visual
discrimination pool using visual stimuli that have a
luminance of approximately 36 cd/m2. These light levels
are likely to saturate any functional rods and is most
likely testing cone function, however, no quantitative
measures of cone photoreceptor survival in the RCS
rat has been done. Other work (Girman, Lu, & Lund,
2003) has shown that rods become dysfunctional early
in the course of degeneration in RCS rats and that trans-
plantation of either Schwann cells or ARPE19 cells fails
to recover rod function even though it promotes rod sur-
vival: most important, the transplants did manage to
limit the further deterioration of cone responsiveness.
On the basis of this, both the control and transplanted
rats would be relying on remaining cone vision for the
responses and the diﬀerences seen between transplanted
and control rats would reﬂect the relative population of
remaining of cones. In the future, variations of the vis-
ual stimuli used in the Visual Water Task may be used
to assess rod or cone function separately.
Although both donor cell types were eﬀective in lim-
iting the loss of spatial vision in this study, there was
nevertheless a gradual deterioration of vision with time.
Whether this reﬂected the inadequacy of cyclosporin as
a complete immunosuppressant (Crafoord, Algvere,
Kopp, & Seregard, 2000; Del Priore et al., 2003) or a
physiological problem associated with other aspects of
graft cell survival or its ability to sustain photoreceptor
rescue is unclear and is the subject of ongoing studies.
For possible application clinically, the ARPE19 cell
line may have an advantage in being homologous to
the defective host RPE and therefore potentially capable
of replacing a number of physiological functions. It does
have the drawbacks in not being syngeneic to the recip-
ient and therefore requiring some level of immunosup-
pression, and in the safety considerations that attend
all cell lines. Schwann cells, however, do appear to sur-
vive without pathological manifestations in the subreti-
nal space and they do have the advantage that they
could be harvested from a peripheral nerve of a patient
and introduced into the subretinal space of that same
patient. In demonstrating in this study that human
Schwann cells have beneﬁt to vision not very diﬀerent
from ARPE19 cells in an animal model of retinal degen-
erative disease, it is clear that with the potential of per-
forming autologous transplantation, the path from
laboratory investigation is signiﬁcantly simpliﬁed with
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